Quent Capital’s Constellation Brands STZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.9K Sell
226
-86
-28% -$13.3K ﹤0.01% 841
2025
Q4
$43K Buy
312
+173
+124% +$23.7K ﹤0.01% 786
2025
Q3
$18.7K Buy
+139
New +$22.1K ﹤0.01% 875
2025
Q2
Sell
-146
Closed -$26.8K 1119
2025
Q1
$26.8K Sell
146
-17
-10% -$3.09K ﹤0.01% 695
2024
Q4
$36K Buy
163
+4
+3% +$950 ﹤0.01% 666
2024
Q3
$41K Sell
159
-28
-15% -$6.94K ﹤0.01% 719
2024
Q2
$48.1K Buy
187
+5
+3% +$1.29K 0.01% 647
2024
Q1
$49.5K Hold
182
0.01% 665
2023
Q4
$44K Hold
182
0.01% 645
2023
Q3
$45.7K Buy
182
+8
+5% +$2.09K 0.01% 605
2023
Q2
$42.8K Sell
174
-20
-10% -$4.68K 0.01% 627
2023
Q1
$43.8K Hold
194
0.01% 629
2022
Q4
$45K Buy
194
+40
+26% +$9.57K 0.01% 607
2022
Q3
$35K Buy
154
+3
+2% +$731 0.01% 636
2022
Q2
$35K Sell
151
-375
-71% -$91.3K 0.01% 604
2022
Q1
$121K Buy
526
+414
+370% +$95.6K 0.02% 382
2021
Q4
$28K Buy
+112
New +$25.5K 0.01% 665

Other funds holding STZ

Quent Capital's STZ Position: Q1 2026 in Review

Quent Capital reduced its Constellation Brands (STZ) stake by 28% in Q1 2026, selling an estimated $13.3K and leaving 226 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Quent Capital first reported a position in STZ in Q4 2021 and has held it in 17 quarters since. The position peaked at $121K in Q1 2022. 1,042 funds tracked by Wall St. Rank hold STZ as of Q1 2026.

  • Quent Capital held 226 shares of Constellation Brands worth $33.9K as of Q1 2026.
  • Quent Capital sold 86 Constellation Brands shares in Q1 2026, an estimated $13.3K.
  • Constellation Brands made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #841 holding.
  • Quent Capital first reported a position in Constellation Brands in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's Constellation Brands position peaked at $121K in Q1 2022.
  • 1,042 funds tracked by Wall St. Rank held Constellation Brands as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.